306 related articles for article (PubMed ID: 26173719)
1. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
[TBL] [Abstract][Full Text] [Related]
2. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
3. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
Brain K; Lifford KJ; Carter B; Burke O; McRonald F; Devaraj A; Hansell DM; Baldwin D; Duffy SW; Field JK
Thorax; 2016 Nov; 71(11):996-1005. PubMed ID: 27471048
[TBL] [Abstract][Full Text] [Related]
4. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
Brain K; Carter B; Lifford KJ; Burke O; Devaraj A; Baldwin DR; Duffy S; Field JK
Thorax; 2017 Oct; 72(10):912-918. PubMed ID: 28710339
[TBL] [Abstract][Full Text] [Related]
5. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
Field JK; Duffy SW; Baldwin DR; Whynes DK; Devaraj A; Brain KE; Eisen T; Gosney J; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rassl DM; Rintoul RC; Screaton NJ; Wald NJ; Weller D; Williamson PR; Yadegarfar G; Hansell DM
Thorax; 2016 Feb; 71(2):161-70. PubMed ID: 26645413
[TBL] [Abstract][Full Text] [Related]
6. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.
Baldwin DR; Duffy SW; Wald NJ; Page R; Hansell DM; Field JK
Thorax; 2011 Apr; 66(4):308-13. PubMed ID: 21317179
[TBL] [Abstract][Full Text] [Related]
7. The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals.
Dunn CE; Edwards A; Carter B; Field JK; Brain K; Lifford KJ
Patient Educ Couns; 2017 Aug; 100(8):1572-1579. PubMed ID: 28274672
[TBL] [Abstract][Full Text] [Related]
8. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.
McRonald FE; Yadegarfar G; Baldwin DR; Devaraj A; Brain KE; Eisen T; Holemans JA; Ledson M; Screaton N; Rintoul RC; Hands CJ; Lifford K; Whynes D; Kerr KM; Page R; Parmar M; Wald N; Weller D; Williamson PR; Myles J; Hansell DM; Duffy SW; Field JK
Cancer Prev Res (Phila); 2014 Mar; 7(3):362-71. PubMed ID: 24441672
[TBL] [Abstract][Full Text] [Related]
9. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
[TBL] [Abstract][Full Text] [Related]
10. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract][Full Text] [Related]
11. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report.
Field JK; Baldwin D; Brain K; Devaraj A; Eisen T; Duffy SW; Hansell DM; Kerr K; Page R; Parmar M; Weller D; Williamson P; Whynes D;
Thorax; 2011 Aug; 66(8):736-7. PubMed ID: 21724746
[TBL] [Abstract][Full Text] [Related]
12. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
13. Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening.
O'Brien MA; Sullivan F; Carson A; Siddiqui R; Syed S; Paszat L
BMC Fam Pract; 2017 Nov; 18(1):95. PubMed ID: 29179686
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
15. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
[TBL] [Abstract][Full Text] [Related]
16. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
Li J; Chung S; Wei EK; Luft HS
BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
[TBL] [Abstract][Full Text] [Related]
17. Attitudes to participation in a lung cancer screening trial: a qualitative study.
Patel D; Akporobaro A; Chinyanganya N; Hackshaw A; Seale C; Spiro SG; Griffiths C;
Thorax; 2012 May; 67(5):418-25. PubMed ID: 22106018
[TBL] [Abstract][Full Text] [Related]
18. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study.
Prout HC; Barham A; Bongard E; Tudor-Edwards R; Griffiths G; Hamilton W; Harrop E; Hood K; Hurt CN; Nelson R; Porter C; Roberts K; Rogers T; Thomas-Jones E; Tod A; Yeo ST; Neal RD; Nelson A
Trials; 2018 Aug; 19(1):419. PubMed ID: 30075741
[TBL] [Abstract][Full Text] [Related]
19. The influence of selected factors on the attendance of the high-risk population in the early lung cancer detection program.
Zakrzewska A; Szczepanowska M; Książek J; Biadacz I; Dziedzic R; Jelitto-Górska M; Rzyman W
Pneumonol Alergol Pol; 2014; 82(1):25-31. PubMed ID: 24391068
[TBL] [Abstract][Full Text] [Related]
20. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
